Inchinn Therapeutics SRL
Inchinn Therapeutics reported total assets of 51,394 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of Inchinn Therapeutics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Total assets -74 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Inchinn Therapeutics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
Inchinn Therapeutics's financial analysis
- Solvency-498.5%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Inchinn Therapeutics
Inchinn Therapeutics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0799.914.755
- VAT number
- BE0799914755
- Peppol
- Registered · 0208:0799914755 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Mar 2023
- Registered office
- 6041 Charleroi
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Inchinn Therapeutics (SRL) has been based in Charleroi since 2023, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 34,948 € and equity of −256,202 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Inchinn Therapeutics
Companies in the same business, of comparable size and area, outside its group.
- RheADC Manufacture of basic pharmaceutical products Leuven · balance sheet 31,395 €
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- MC Pharma Manufacture of basic pharmaceutical products Beaumont · balance sheet 28,699 €
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Mentana DX Research and experimental development on natural sciences and engineering Evergem · balance sheet 229,998 €
- Attito Management Manufacture of pharmaceutical preparations Kapelle-op-den-Bos · balance sheet 131,498 €
- OncoRNA Research and experimental development on natural sciences and engineering Charleroi · balance sheet 20,034 €
- Raya Therapeutic Manufacture of basic pharmaceutical products Leuven · balance sheet 5,330 €
Frequently asked questions about Inchinn Therapeutics
What is the revenue of Inchinn Therapeutics?
Inchinn Therapeutics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Inchinn Therapeutics?
In Belgium, the VAT number is the company number prefixed with BE: BE0799914755 for Inchinn Therapeutics, if the company is VAT-registered. Its company number (CBE) is 0799.914.755.
Where is the registered office of Inchinn Therapeutics?
According to the CBE register, the registered office of Inchinn Therapeutics is in 6041 Charleroi.
What is the equity of Inchinn Therapeutics?
At the close of the 2025 financial year, the equity of Inchinn Therapeutics amounts to -256,202 €, a solvency of -498.5% of total assets.
Who manages Inchinn Therapeutics?
The register lists 1 active mandates at Inchinn Therapeutics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Inchinn Therapeutics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →